Skip to content

Insider · CIK 0001994792

Jonathan Del Lockett

officer

Files at HIT (Health In Tech, Inc.). First filing -, latest -.

In brief

Jonathan Del Lockett files SEC Form 4 as officer at HIT (Health In Tech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Jonathan Del Lockett has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 20, 2026HIT
Health In Tech, Inc.
AGrant or award
Class A Common Stock
+50,000$0.00$0143,539May 22, 2026
Aug 15, 2025HIT
Health In Tech, Inc.
AGrant or award
Class A Common Stock
+7,000$0.00$093,539Aug 19, 2025

Questions about Jonathan Del Lockett

Answered from the filings on this page, as of the latest one.

Is Jonathan Del Lockett buying or selling?

Jonathan Del Lockett has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Jonathan Del Lockett's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Del Lockett has 0.

Where does Jonathan Del Lockett file Form 4?

Jonathan Del Lockett has filed Form 4 at HIT (Health In Tech, Inc.) as Chief Strategy Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jonathan Del Lockett: insider trades and track record | InsiderTell